1. Home
  2. BNC vs SLN Comparison

BNC vs SLN Comparison

Compare BNC & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CEA Industries Inc.

BNC

CEA Industries Inc.

HOLD

Current Price

$3.21

Market Cap

287.3M

Sector

Industrials

ML Signal

HOLD

Logo Silence Therapeutics Plc American Depository Share

SLN

Silence Therapeutics Plc American Depository Share

HOLD

Current Price

$6.95

Market Cap

236.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNC
SLN
Founded
N/A
1994
Country
United States
United Kingdom
Employees
N/A
116
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
287.3M
236.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BNC
SLN
Price
$3.21
$6.95
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$42.60
AVG Volume (30 Days)
233.6K
398.6K
Earning Date
07-24-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.22
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.39
$4.19
52 Week High
$31.62
$8.40

Technical Indicators

Market Signals
Indicator
BNC
SLN
Relative Strength Index (RSI) 54.94 49.52
Support Level $2.93 $5.91
Resistance Level $4.14 $7.21
Average True Range (ATR) 0.21 0.44
MACD 0.05 -0.12
Stochastic Oscillator 73.75 13.95

Price Performance

Historical Comparison
BNC
SLN

About BNC CEA Industries Inc.

CEA Industries Inc through its subsidiary is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture ("CEA") industry. The company provides integrated mechanical, electrical, and plumbing ("MEP") engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. The Company has one operating segment that is dedicated to the manufacture and sale of its products.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Share on Social Networks: